Iaso Ventures — 2024 Investments

3 investments dated 2024 · listed companies and verified rows first · show all

Axonis Therapeuticsaxonis.us inOct 2024

Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.

BiotechDeep TechBoston, US

Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)in Jeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in

Board Corey . Goodman(Director)in Jonathan Leff(Director)in

Co-investorsSofinnova Ventures venBio Partners MRL Ventures Fund Civilization Ventures Management, Llc Creative Destruction Lab (CDL)Hatteras Venture Partners +8 more

Neurona Therapeuticsneuronatherapeutics.com inJul 2024 · $120M

Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system.

BiotechDeep TechHealthtechSouth San Francisco, US

Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Chief Financial Officer and Chief Business Officer)in Catherine Priest(Chief Development Officer)in Gautam Banik(Chief Technology Officer)inEduardo Dunayevich(Chief Medical Officer)inArnold Kriegstein(Director)

Co-investorsBerkeley Frontier The Column Group Viking Global Ysios Capital Alexandria Fidelity Investments +8 more

Zenith Healthzenithhealth.ioPre-Seed · Aug 2024

Zenith was a women's health company offering an app and an AI assistant called Penny to support women through pregnancy with information and guidance.

Digital HealthFemTechHealthtech

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.